Lonza Tampa LLC

Form 483 issued October 1, 2021 · TAMPA, Florida

Inspection
Sep 27 – Oct 1, 2021
Observations
2
Pages
4
FEI number
3001549109

In short: On October 1, 2021, FDA issued a Form 483 with 2 observations to Lonza Tampa LLC in TAMPA, Florida (FEI 3001549109) after an inspection that ran Sep 27 – Oct 1, 2021. The investigators were Kayla V. Sprague and Lillian M. Colon-Mcknight. Most observations concern quality system and production.

At a glance

Quality system and production account for 2 of 2 observations.

Quality system1
Production1

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    The quality control unit lacks authority to review production records to assure that no errors have…

  2. 02

    The master production and control records are deficient in that they do not include complete manufacturing…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Lonza Tampa LLC?

FDA listed 2 observations on this Form 483, mostly about quality system and production. The opening words of each observation are shown on this page.

Who inspected Lonza Tampa LLC?

Kayla V. Sprague and Lillian M. Colon-Mcknight are named on this Form 483, for the inspection of Sep 27 – Oct 1, 2021. Each investigator has a profile showing what they cite most.

When was Lonza Tampa LLC inspected by FDA?

The inspection ran Sep 27 – Oct 1, 2021, and the Form 483 is dated October 1, 2021.

How do I get the full Form 483 for Lonza Tampa LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free